Latest Asx News

Austco Healthcare kicks off FY26 with a robust 51% revenue increase and improved profitability, driven by strong organic growth and strategic acquisitions.

Tali Resources has identified the Lonar East prospect, a significant new gravity and magnetic anomaly at its West Arunta Project, signalling promising potential for large-scale mineralisation. The company is advancing plans for targeted drilling to unlock the prospect's value.

Ballard Mining has raised $20.6 million through a premium share placement led by new strategic investor Aurenne Group Holdings, aiming to accelerate exploration and resource growth at its Mt Ida Gold Project. A new, substantial October 2025 Exploration Target highlights significant upside beyond the existing mineral resources.

Artemis Resources has reported a significant high-grade gold intersection in its maiden drill hole at the Titan East Prospect, signalling promising expansion potential near its Carlow resource.

Pursuit Minerals progresses its Rio Grande Sur lithium project with a refined commercial plan and feasibility study, while expanding into gold through the Sascha Marcelina acquisition. A recent $4 million placement strengthens its financial position for growth.

IRIS Metals’ Phase II drilling at the Tin Mountain Project confirms exceptional lithium grades and unveils critical minerals like rubidium, positioning the company as a key player in the US critical minerals landscape.

Australian Rare Earths Limited (ASX, AR3) reported strong progress in its Koppamurra Rare Earths Project with high recovery rates and production milestones, while also expanding and resuming drilling at its Overland Uranium Project. The company bolstered its financial position through government grants and option exercises.

Terra Metals has reported multiple new zones of massive and semi-massive sulfide mineralisation at its Southwest Prospect within the Dante Project, signalling a potentially large-scale, multi-metal magmatic system. Assay results are pending as drilling and geophysical surveys continue.

Amplia Therapeutics reports encouraging interim results for narmafotinib in metastatic pancreatic cancer, alongside a successful capital raise and key patent allowance.

Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.

Adslot Ltd reports solid progress in Q1 FY26, highlighting growth in its StoreFront and Marketplace platforms alongside a successful $989,000 capital raise to fuel expansion.

Tyranna Resources has advanced its exploration and acquisition efforts in Angola, securing a major stake in the Chinguar Gold Project and extending its lithium-caesium project tenure, supported by a solid cash position.